Joint Procurement of medical countermeasures

The outbreak in 2009 of H1N1 pandemic influenza highlighted weaknesses in respect of equitable access and purchasing power to obtain correct contractual conditions on price, liability, confidentiality and flexibility to adjust the quantities ordered to actual needs, in the mechanisms in place in EU countries for procuring pandemic vaccines and medications. 

In 2010, the Council requested the Commission to start the preparation of a Joint Procurement of vaccines in the frame of a future pandemicpdf.

Ensuring proper preparedness for outbreaks of threats to health

In order to be prepared for an outbreak of a serious cross-border threat to health, the institutions of the EU and any Member States may engage in a joint procurement procedure with a view to purchase medical countermeasures, so that:

  • pandemic vaccines and other medical countermeasures are available in sufficient quantities;
  • access to pandemic vaccines or medical countermeasures is guaranteed for all participating Member States;
  • all Member States are treated equally and can benefit from correct contractual conditions.

The Joint Procurement Agreementpdf(128 KB) that precedes the joint procurement procedure:

  • determines the practical arrangements governing that procedure;
  • defines the decision-making process with regard to the choice of the procedure;
  • organizes the assessment of the tenders and the award of the contract.

The Joint Procurement Agreement enters into force once one third of the participating Member States have signed it.

Legal basis

The Article 5 the Decision 1082/2013/EUpdf(808 KB) Choose translations of the previous link български (bg) čeština (cs) dansk (da) Deutsch (de) eesti keel (et) ελληνικά (el) español (es) français (fr) italiano (it) latviešu valoda (lv) lietuvių kalba (lt) magyar (hu) Malti (mt) Nederlands (nl) polski (pl) português (pt) română (ro) slovenčina (sk) slovenščina (sl) suomi (fi) svenska (sv)  

See also: